Literature DB >> 23314799

Multiple antiplatelet therapy contributes to the reversible high signal spots on diffusion-weighted imaging in elective coiling of unruptured cerebral aneurysm.

Toshinori Matsushige1, Yoshihiro Kiura, Shigeyuki Sakamoto, Takahito Okazaki, Katsuhiro Shinagawa, Nobuhiko Ichinose, Miyuki Takasu, Yuji Akiyama, Kazuhiko Sugiyama, Kaoru Kurisu.   

Abstract

INTRODUCTION: Our aim was to systematically investigate radiographic characteristics and outcome of diffusion-weighted imaging (DWI) changes in the elective coiling of unruptured cerebral aneurysm with analyzing the correlation of antiplatelet therapy (APT).
METHODS: In a total of 34 consecutive patients with unruptured cerebral aneurysms initially treated by coiling without stent assist, 26 (76.5%) had DWI changes with 91 high signal spots within 24-48 h after the procedure. We recorded DWI parameters (location, volume, mean, and minimum values of the apparent diffusion coefficient: expressed as ADCAVE and ADCMIN) for each lesion, and evaluated its radiographic outcome on conventional MRI at follow-up (interval, 58.4 ± 37.2 days) in the modes of APT.
RESULTS: All patients with DWI high spots had no clinical symptoms. There was a strong correlation between ADCAVE and ADCMIN (r = 0.82, p < 0.0001). The mean ADCAVE and rADCAVE were 0.74 ± 0.14 × 10(-3) mm(2)/s and 87 ± 10 %. DWI high spots were small with a mean volume of 0.13 ± 0.12 cm(3), ranging from 0.04 to 0.86 cm(3). A negative correlation was observed between the volume and values of ADCAVE (r = -0.48, p < 0.0001). The DWI volume was significantly larger in single APT than in multiple (0.15 ± 0.14 versus 0.10 ± 0.07 cm(3), p = 0.0091). The permanent signal change was more observed in single APT than in multiple (24.5% versus 5.2%, p = 0.02).
CONCLUSION: DWI high spots after elective coiling were small without significant decrease of ADC, and do not correspond to brain infarction. Periprocedural use of multiple antiplatelet agents is expected to reduce the volume of thromboembolism and permanent tissue damages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314799     DOI: 10.1007/s00234-013-1137-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke.

Authors:  G Schlaug; B Siewert; A Benfield; R R Edelman; S Warach
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

2.  Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?

Authors:  C Oppenheim; C Lamy; E Touzé; D Calvet; M Hamon; J-L Mas; J-F Méder
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Silent thromboembolic events associated with the treatment of unruptured cerebral aneurysms by use of Guglielmi detachable coils: prospective study applying diffusion-weighted imaging.

Authors:  G Rordorf; R J Bellon; R E Budzik; J Farkas; G F Reinking; R S Pergolizzi; M Ezzeddine; A M Norbash; R G Gonzalez; C M Putman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

4.  Periprocedural morbidity and mortality by endovascular treatment of cerebral aneurysms with GDC: a retrospective 12-year experience of a single center.

Authors:  G B Bradac; M Bergui; G Stura; M Fontanella; D Daniele; L Gozzoli; M Berardino; A Ducati
Journal:  Neurosurg Rev       Date:  2007-01-11       Impact factor: 3.042

5.  Diffusion MRI in patients with transient ischemic attacks.

Authors:  C S Kidwell; J R Alger; F Di Salle; S Starkman; P Villablanca; J Bentson; J L Saver
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

6.  Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils.

Authors:  Michael J Workman; Harry J Cloft; Frank C Tong; Jacques E Dion; Mary E Jensen; William F Marx; David F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

7.  Thromboembolic events associated with endovascular treatment of cerebral aneurysms.

Authors:  Tamer Altay; Hee I Kang; Henry H Woo; Thomas J Masaryk; Peter A Rasmussen; David J Fiorella; Shaye I Moskowitz
Journal:  J Neurointerv Surg       Date:  2011-01-08       Impact factor: 5.836

8.  Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome.

Authors:  M Cronqvist; R Wirestam; B Ramgren; L Brandt; O Nilsson; H Säveland; S Holtås; E-M Larsson
Journal:  Neuroradiology       Date:  2005-10-19       Impact factor: 2.804

9.  Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study.

Authors:  Laurent Pierot; Laurent Spelle; Fabien Vitry
Journal:  Stroke       Date:  2008-07-10       Impact factor: 7.914

10.  Cerebral aneurysms treated by Guglielmi detachable coils: evaluation with diffusion-weighted MR imaging.

Authors:  A Biondi; C Oppenheim; E Vivas; A Casasco; T Lalam; N Sourour; L L Jean; D Dormont; C Marsault
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  3 in total

1.  Patency of the anterior choroidal artery after flow-diversion treatment of internal carotid artery aneurysms.

Authors:  W Brinjikji; D F Kallmes; H J Cloft; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-22       Impact factor: 3.825

2.  Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery.

Authors:  Shigeyuki Sakamoto; Yoshihiro Kiura; Yosuke Kajihara; Masaaki Shibukawa; Takahito Okazaki; Toshinori Matsushige; Katsuhiro Shinagawa; Kazutoshi Mukada; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2013-06-21       Impact factor: 3.042

3.  Efficacy of dual antiplatelet therapy as premedication before diagnostic cerebral digital subtraction angiography.

Authors:  Yoon-Hee Choo; Young-Jin Jung; Chul-Hoon Chang; Jong-Hoon Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.